• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心房颤动的射频导管消融术的成功率:肥胖会影响结果吗?

Success of Radiofrequency Catheter Ablation of Atrial Fibrillation: Does Obesity Influence the Outcomes?

作者信息

Lakkireddy Dhanunjaya R, Blake George E, Patel Dimpi, Rotter Martin, Verma Atul, Ryschon Kay, Khan Mohammed, Schweikert Robert, Haissaguerre Michel, Natale Andrea

机构信息

Mid America Cardiology @ University of Kansas Hospital, Kansas City, KS.

Cleveland Clinic Founda tion, Cleveland, OH.

出版信息

J Atr Fibrillation. 2008 May 16;1(1):36. doi: 10.4022/jafib.36. eCollection 2008 May-Jun.

DOI:10.4022/jafib.36
PMID:28496572
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5398797/
Abstract

Catheter ablation of atrial fibrillation (AF) is an increasingly popular therapeutic option for symptomatic patients who have failed multiple antiarrhythmic drugs (AADs). Patients of higher body mass index often fail direct current cardioversion. The role of body mass index (BMI) on the success of AF ablation is not well understood. We prospectively studied 511 patients who underwent AF ablation at the Cleveland Clinic Foundation between 2002 and 2005. Patients were divided into four classes based on their BMI: Class I ( 25); Class II (25.1-30); Class III (30.1-35) and Class IV (>35). These groups were compared for baseline demographic and clinical characteristics. Any recurrence of AF after 3 months of ablation was considered as failure. All classes were followed for at least 12 months and rates of failure were compared. Based on their BMI, 25% of patients were assigned to class I, 37% in class II, 21% in class III and 16% in class IV. Patients of higher classification (class III or IV) were more likely to be male (p<0.001), diabetic (p<0.001), smokers (p=0.002), with coronary artery disease (=0.018), left atrial enlargement (p=0.015) and longstanding AF (p=0.007). Severity of obesity as measured by BMI had a direct correlation to early (p=0.05) and late (p=0.01) recurrence of AF. Obesity is significantly associated with long-term AF recurrence after catheter ablation. Higher incidence of smoking & left atrial enlargement may possibly contribute to higher failure rates in this sub-group of patients.

摘要

对于多种抗心律失常药物(AADs)治疗失败的有症状房颤(AF)患者,导管消融术是一种越来越受欢迎的治疗选择。体重指数较高的患者常无法通过直流电复律成功转复。体重指数(BMI)对房颤消融成功率的作用尚未完全明确。我们对2002年至2005年间在克利夫兰诊所基金会接受房颤消融术的511例患者进行了前瞻性研究。根据BMI将患者分为四类:I类(<25);II类(25.1 - 30);III类(30.1 - 35)和IV类(>35)。比较这些组的基线人口统计学和临床特征。消融术后3个月内房颤的任何复发都被视为失败。对所有类别患者至少随访12个月,并比较失败率。根据BMI,25%的患者被归为I类,37%为II类,21%为III类,16%为IV类。分类较高(III类或IV类)的患者更可能为男性(p<0.001)、糖尿病患者(p<0.001)、吸烟者(p = 0.002),患有冠状动脉疾病(p = 0.018)、左心房扩大(p = 0.015)和长期房颤(p = 0.007)。通过BMI衡量的肥胖严重程度与房颤的早期(p = 0.05)和晚期(p = 0.01)复发直接相关。肥胖与导管消融术后房颤的长期复发显著相关。吸烟和左心房扩大的较高发生率可能是导致该亚组患者较高失败率的原因。

相似文献

1
Success of Radiofrequency Catheter Ablation of Atrial Fibrillation: Does Obesity Influence the Outcomes?心房颤动的射频导管消融术的成功率:肥胖会影响结果吗?
J Atr Fibrillation. 2008 May 16;1(1):36. doi: 10.4022/jafib.36. eCollection 2008 May-Jun.
2
Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation.体重指数对心房颤动消融术后心血管事件的长期影响。
J Interv Card Electrophysiol. 2016 Sep;46(3):259-65. doi: 10.1007/s10840-016-0142-5. Epub 2016 May 20.
3
Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.肥厚型心肌病患者心房颤动的导管消融:心房颤动类型决定成功率。
Kardiol Pol. 2013;71(1):17-24.
4
Increased rates of atrial fibrillation recurrence following pulmonary vein isolation in overweight and obese patients.超重和肥胖患者行肺静脉隔离术后心房颤动复发率增加。
J Cardiovasc Electrophysiol. 2018 Feb;29(2):239-245. doi: 10.1111/jce.13388. Epub 2017 Dec 14.
5
Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.经直流电复律术参数预测持续性心房颤动导管消融的长期预后。
J Cardiovasc Electrophysiol. 2012 Nov;23(11):1165-70. doi: 10.1111/j.1540-8167.2012.02339.x. Epub 2012 Aug 8.
6
Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial.导管消融治疗心房颤动后短期应用抗心律失常药物的疗效(EAST-AF 试验)。
Eur Heart J. 2016 Feb 14;37(7):610-8. doi: 10.1093/eurheartj/ehv501. Epub 2015 Sep 28.
7
Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation.广泛应用抗心律失常药物恢复窦性心律对预测持续性心房颤动导管消融结果的影响。
Am J Cardiol. 2010 Jul 1;106(1):62-8. doi: 10.1016/j.amjcard.2010.02.016. Epub 2010 May 18.
8
Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.房颤导管消融术后短期使用抗心律失常药物的疗效——一项随机对照试验的系统评价、荟萃分析及试验序贯分析
PLoS One. 2016 May 25;11(5):e0156121. doi: 10.1371/journal.pone.0156121. eCollection 2016.
9
Catheter ablation of inducible atrial flutter, in combination with atrial pacing and antiarrhythmic drugs ("hybrid therapy") improves rhythm control in patients with refractory atrial fibrillation.导管消融可诱发的心房扑动,联合心房起搏和抗心律失常药物(“混合疗法”)可改善难治性心房颤动患者的节律控制。
J Interv Card Electrophysiol. 2002 Jun;6(2):165-72. doi: 10.1023/a:1015319618049.
10
Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.采用逐步法消融持续性心房颤动 5 年后的随访及成功的预测因素。
Circ Arrhythm Electrophysiol. 2015 Apr;8(2):308-17. doi: 10.1161/CIRCEP.114.001672. Epub 2015 Mar 5.

引用本文的文献

1
Obesity as a risk factor in atrial fibrillation and heart failure.肥胖作为心房颤动和心力衰竭的一个风险因素。
J Diabetes Metab Disord. 2023 Oct 25;23(1):125-134. doi: 10.1007/s40200-023-01332-z. eCollection 2024 Jun.
2
Obesity effect on newly diagnosed and recurrent post-ablation atrial fibrillation: a systematic review and meta-analysis.肥胖对新诊断和复发性消融后心房颤动的影响:系统评价和荟萃分析。
J Endocrinol Invest. 2024 May;47(5):1051-1066. doi: 10.1007/s40618-023-02225-x. Epub 2023 Nov 14.
3
Impact of abdominal obesity on outcomes of catheter ablation in Korean patients with atrial fibrillation.腹型肥胖对韩国心房颤动患者导管消融结局的影响。
Int J Clin Pract. 2021 Oct;75(10):e14696. doi: 10.1111/ijcp.14696. Epub 2021 Aug 6.
4
Proceedings From the 2019 Stanford Single Ventricle Scientific Summit: Advancing Science for Single Ventricle Patients: From Discovery to Clinical Applications.2019 年斯坦福单心室科学峰会会议录:推进单心室患者的科学研究:从发现到临床应用。
J Am Heart Assoc. 2020 Apr 7;9(7):e015871. doi: 10.1161/JAHA.119.015871. Epub 2020 Mar 19.
5
Disease-treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue.肥胖和糖尿病合并心房颤动患者管理中的疾病-治疗相互作用:心外膜脂肪组织的潜在中介影响。
Cardiovasc Diabetol. 2019 Sep 24;18(1):121. doi: 10.1186/s12933-019-0927-9.

本文引用的文献

1
Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.体重指数、阻塞性睡眠呼吸暂停与心房颤动导管消融的结果
J Cardiovasc Electrophysiol. 2008 Jul;19(7):668-72. doi: 10.1111/j.1540-8167.2008.01118.x. Epub 2008 Mar 21.
2
Management of atrial fibrillation.心房颤动的管理
Lancet. 2007 Aug 18;370(9587):604-18. doi: 10.1016/S0140-6736(07)61300-2.
3
The endothelium and vascular inflammation in diabetes.糖尿病中的内皮细胞与血管炎症
Diab Vasc Dis Res. 2007 Jun;4(2):84-8. doi: 10.3132/dvdr.2007.025.
4
Atrial fibrillation, obesity, and obstructive sleep apnea.
Arch Intern Med. 2007 Jul 23;167(14):1552-3; author reply 1553. doi: 10.1001/archinte.167.14.1552-c.
5
Smoking, oxidative stress and cardiovascular diseases--do anti-oxidative therapies fail?吸烟、氧化应激与心血管疾病——抗氧化疗法是否无效?
Curr Med Chem. 2007;14(16):1703-12. doi: 10.2174/092986707781058959.
6
Percutaneous catheter ablation of atrial fibrillation.经皮导管消融治疗心房颤动。
Expert Rev Cardiovasc Ther. 2007 Jul;5(4):693-705. doi: 10.1586/14779072.5.4.693.
7
Systemic effects of smoking.吸烟的全身效应。
Chest. 2007 May;131(5):1557-66. doi: 10.1378/chest.06-2179.
8
Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation.代谢综合征对新发心房颤动患者心房大小的影响。
Angiology. 2007 Feb-Mar;58(1):21-5. doi: 10.1177/0003319706297913.
9
Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.阻塞性睡眠呼吸暂停、肥胖与房颤发生风险
J Am Coll Cardiol. 2007 Feb 6;49(5):565-71. doi: 10.1016/j.jacc.2006.08.060. Epub 2007 Jan 22.
10
High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome.代谢综合征中阵发性心房颤动和/或心房扑动的高患病率。
Circ J. 2007 Feb;71(2):252-5. doi: 10.1253/circj.71.252.